Affiliation:
1. Federal State Autonomous Educational Institution of Higher Education "Peoples Friendship University of Russia"
Abstract
The analysis of the clinical and immunological effectiveness of the drug Immunomax® in the treatment of chronic diseases of bacterial, viral, or mixed etiology. Analysis of bibliographic systems shows an increase in publications devoted to the analysis of the clinical and immunological efficacy of the Immunomax® drug, which indicates the attention of researchers to this immunomodulator, the validity of its use in dysfunctions of factors of innate and adaptive immunity arising from bacterial and viral infections, secondary immunodeficiency states with impaired killer, phagocytic functions of secretory mechanisms, the process of generating and maintaining the balance of cytokines.
Publisher
PANORAMA Publishing House
Reference14 articles.
1. Dyadina K. S. Vestnik novykh meditsinskikh tekhnologiy. elektronnoe izdanie (Journal of New Medical Technologies, eJournal). 2020; 14 (2): 123–127.
2. Letyaeva O. I., Gizinger O. A. Ginekologiya (Gynecology). 2011; 13 (1): 16–21.
3. Babu S., Blauvelt C. P., Kumaraswami V., Nutman T. B. Cutting edge: diminished T cell TLR expression and function modulates the immune response in human fi larial infection. J. Immunol. 2006; 176 (7): 3885–3389.
4. Bagaev A., Pichugin A., Nelson E. L., Agadjanyan M. G., Ghochikyan A., Ataullakhanov R. I. Anticancer mechanisms in two murine bone marrow-derived dendritic cell subsets activated with TLR4 agonists. J. Immunol. 2018; 200 (8): 2656–2669.
5. Pinegin B. V., Khaitov R. M. Immunologiya. 2019; 40 (6): 13–17.